Respira Therapeutics Announces Agreement with Gossamer Bio for Potential Acquisition Respira Therapeutics has entered a pivotal agreement with Gossamer Bio to develop RT234, a groundbreaking therapy for pulmonary hypertension, enhancing patient relief options.

Respira Therapeutics Announces Agreement with Gossamer Bio for Potential Acquisition #United_States #Palo_Alto #Respira_Therapeutics #Gossamer_Bio #RT234

For this week’s then and now, we’re back to the Prince William County Library’s RELIC slide collection. #pwchistory #I95 #Rt234 #dumfries #crackerbarrel #thenandnow